RecruitingNCT06015776

Purinergic Signaling and the Postmenopausal Heart

PGC-1, Purines and the Postmenopausal Heart


Sponsor

Beth Israel Deaconess Medical Center

Enrollment

500 participants

Start Date

Jul 1, 2019

Study Type

OBSERVATIONAL

Conditions

Summary

There is an increased risk of diastolic heart failure in post menopausal women. Estrogen plays a positive role in regulating molecular pathways in heart remodeling. Such pathways may work through purinergic signaling and its downstream effects on the heart's mitochondrial metabolism and angiogenic response to stress. Loss of estrogen functionality in post menopausal women may account for the increased risk of diastolic heart failure. The investigators will explore said pathways using cardiac tissue obtained from patients undergoing cardiac surgery.


Eligibility

Min Age: 30 YearsMax Age: 88 Years

Plain Language Summary

Simplified for easier understanding

This study investigates how the heart's chemical communication system — called purinergic signaling, which involves molecules like ATP that help regulate heart rhythm and function — works differently in postmenopausal women compared to other patients during open-heart surgery. Menopause causes hormonal changes that may affect how the heart copes with the stress of surgery, and this study aims to understand those differences. **You may be eligible if...** - You are scheduled for open-heart surgery that requires a heart-lung bypass machine (cardiopulmonary bypass) **You may NOT be eligible if...** - You refuse to participate - Your surgery is an emergency - You have a pre-existing heart block or atrial fibrillation (irregular heart rhythm) - You are having redo heart surgery - You are currently taking estrogen or any hormone replacement therapy - You have a history of chronic heart failure or major kidney disease Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERGender

Differences between men and women will be observed


Locations(1)

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06015776


Related Trials